Maternal colonization or infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae in Africa: A systematic review and meta-analysis
Open accessAbstract
OBJECTIVE: To summarize published studies on the prevalence of and risk factors for maternal bacterial colonization and/or infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E) in pregnant and/or post-partum women in Africa. METHODS: A systematic review was conducted using the PubMed, Scopus, and Google Scholar databases. Bibliographies of included eligible studies were manually searched to identify additional relevant articles. No language restriction was applied. The timeframe of the search included all records from electronic database inception to July 15, 2017. A random-effects meta-analysis was performed to summarize the prevalence and the 95% confidence intervals (CI) of ESBL-E colonization or infection in pregnant or post-partum women in Africa. The meta-analysis was conducted using STATA IC 13.1 software and the metaprop function/plugin. RESULTS: Ten studies (seven on pregnant women and three on post-partum women) were included, documenting a 17% prevalence of maternal colonization with ESBL-E in Africa (95% CI 10-23%). The prevalence of ESBL-E in community isolates exceeded that in isolates from the hospital setting (22% vs. 14%). The most frequently reported ESBL-encoding gene was CTX-M (cefotaxime hydrolyzing capabilities). Data on risk factors for maternal ESBL-E colonization and infection are very limited. CONCLUSIONS: The prevalence of colonization and/or infection with ESBL-E in pregnant and post-partum women in Africa exceeds that reported from high- and middle-income settings, representing a risk for subsequent neonatal colonization and/or infection with ESBL-E.
AI snapshot
Written from the paper’s full text.
TL;DR
This systematic review and meta-analysis found that 17% (95% CI 10–23%) of pregnant and post-partum women in Africa were colonized or infected with extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E). The authors conclude this exceeds rates reported from high- and middle-income settings and represents a risk for subsequent neonatal colonization and/or infection.
Key findings
- Pooled ESBL-E prevalence was 17% (95% CI 10–23%) across 10 included observational studies, with high heterogeneity (I² = 93.6%, p < 0.001).
- Pooled prevalence was higher in pregnant women (22%, 95% CI 12–31%) than post-partum women (7%, 95% CI 2–12%), and higher in community settings (22%, 95% CI 9–34%) than hospital settings (14%, 95% CI 5–23%).
- Colonization prevalence (19%, 95% CI 10–27%) exceeded infection prevalence (13%, 95% CI −1–27%).
- CTX-M was the most frequently reported ESBL-encoding gene; risk-factor data were limited, with three studies reporting independent factors including private indoor drinking water access (OR 3.8, 95% CI 1.2–11.6), living in an individual house (OR 2.2, 95% CI 1.0–4.8), antimicrobial activity in stool (OR 5.4, 95% CI 2.0–14.7), single marital status (OR 2.6, 95% CI 1.1–6.1), CD4+ count <200/ml (OR 2.9, 95% CI 1.1–7.7), and current UTI symptoms (OR 2.5, 95% CI 1.1–6.0).
Methods
- Systematic review and random-effects meta-analysis of observational studies reporting ESBL-E colonization and/or infection in pregnant or post-partum women in Africa, searching PubMed, Scopus, and Google Scholar from database inception to July 15, 2017, with no language restriction.
- Ten studies were included (from Nigeria, Tanzania, Madagascar, South Africa, Mozambique, Uganda, and Cameroon); 1,304 participants were pooled (927 pregnant women and 377 post-partum women).
- Proportions were pooled using the Freeman-Tukey arcsine methodology in STATA IC 13.1 with the metaprop function/plugin; heterogeneity was assessed with the I² statistic, and risk of bias was assessed with an adapted Newcastle-Ottawa Scale.
Limitations
- The authors state that the number of eligible studies was small, showing a lack of research in this population, and that findings may not be generalizable to all pregnant and/or post-partum women in Africa.
- The authors note that all included studies were observational, a design prone to selection and information biases.
- The paper reports high heterogeneity (I² = 93.6%, p < 0.001), and the text contains an internal inconsistency in study counts: the abstract states seven studies on pregnant women and three on post-partum women, while the Results section states six and four, respectively.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
13 of 33 cited sources checked · 2 supported · 0 flagged · accuracy not yet measured
- Findingcitation
Chereau et al. (2015) identified living in an individual house (OR 2.2, 95% CI 1.0-4.8) as an independent risk factor for ESBL-E colonization among Malagasy women.
“Chereau et al. (2015) identified private indoor access to drinking water (odds ratio (OR) 3.8, 95% CI 1.2-11.6)and living in an individual house (OR 2.2, 95% CI 1.0-4.8)as independent risk factors for ESBL-E colonization among Malagasy women (after adjusting for”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Chereau et al. (2015) source
Table 2 reports the stated multivariate odds ratio for living in an individual house among pregnant women in Madagascar (OR 2.2, 95% CI 1.0–4.8). But its P value is 0.06, above the paper’s 0.05 significance threshold, so calling it an independent risk factor overstates the statistical evidence. The paper also cautions that risk factors should be interpreted carefully because the study was cross-sectional. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Premisecitation
Several studies have confirmed the role of maternal colonization in the subsequent development of neonatal sepsis, particularly for group B Streptococcus but also for ESBL-E.
“Several studies have confirmed the role of maternal colonization in the subsequent development of neonatal sepsis (particularly for group B Streptococcus, but also for ESBL-E) (Chan et al., 2013;Kaba et al., 2016;Denkel et al., 2014;Rettedal et al., 2015).”
Quote in the paperNot a substantial claim2 of 3 sources checked- cites Chan et al., 2013 source
The Results (Meta-analyses; page not specified) report higher odds of neonatal infection among newborns of mothers colonized with group B Streptococcus, supporting that part of the claim. The passages on other pathogens discuss E. coli colonization but do not identify ESBL-E or establish an association between maternal ESBL-E colonization and neonatal sepsis. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites Kaba et al., 2016 source
The Results (section labeled “2 ∙ M.P. Nicol”; page not given) report ESBL-producing bacterial carriage in mothers and infants and clonally related isolates in one mother–infant pair. This supports a possible link in colonization, but the study of apparently healthy infants does not report neonatal sepsis or establish that maternal colonization led to it. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites Denkel et al., 2014 source
- Interpretationcitation
The molecular epidemiology of ESBL-E enzymes identified in the Madagascar, Nigeria, Cameroon, and Mozambique studies was in keeping with the global predominance of the CTX-M clone.
“The molecular epidemiology of the ESBL-E enzymes identified in the Madagascar (Chereau et al., 2015), Nigeria (Fortini et al., 2015), Cameroon (Djuikoue et al., 2016b), and Mozambique (Sáez-lópez et al., 2016) studies was in keeping with the global predominance of the CTX-M clone, which is also widely reported in community-acquired UTI (Pitout et al., 2005;Peirano and Pitout, 2010;Pallecchi et al.”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites Pitout et al., 2005 source
- cites Peirano and Pitout, 2010 source
- cites Pallecchi et al., 2004 source
The Abstract (page unavailable) says CTX-M-type enzymes have been reported in clinical isolates from community-acquired infections, and the Discussion describes them as important emerging ESBLs worldwide. But the passage does not identify those infections as UTIs or establish that CTX-M is widely reported specifically in community-acquired UTI. The cited paper studied fecal isolates from healthy children, not UTI cases. (LLM, conf=0.84)
Experimental — accuracy not yet measured
- Findingcitation
Drinking water supply from a spring or a well was not significantly associated with ESBL-E colonization/infection.
“The following elements were not found to be significantly associated with ESBL-E colonization/infection in these three studies: being employed or being a housewife (Tito et al. 2017), drinking water supply from a spring or a well (Chereau et al., 2015), and hospitalization in the last 3 months (Djuikoue et al. 2016a,b).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Chereau et al., 2015 source
- Findingcitation
Bebell et al. (2017) identified low CD4+ count of <200/ml (OR 2.9, 95% CI 1.1-7.7, p=0.031) as an independent predictor of ESBL-E infection.
“Bebell et al. ( 2017)) identified single marital status (OR 2.6, 95% CI 1.1-6.1,p = 0.026), low CD4+ count of <200/ml (OR 2.9, 95% CI 1.1-7.7,p = 0.031), and current UTI symptoms (OR 2.5, 95% CI 1.1-6.0,p = 0.03) as independent predictors of ESBL-E infection.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Bebell et al. (2017) source
The Results (Enrollment and demographics, Table 1; page unavailable) compare CD4 categories between women with and without confirmed infection, not ESBL-E infection. The Methods (Data entry and statistical analysis; page unavailable) describe group comparisons, and the Results (Urinary tract infections; page unavailable) report ESBL prevalence. Searches for the stated odds ratio, confidence interval, p-value, and independent-predictor analysis found no passage reporting the claimed association. (LLM, conf=0.78)
Experimental — accuracy not yet measured
- Findingcitation
Chereau et al. (2015) identified private indoor access to drinking water (OR 3.8, 95% CI 1.2-11.6) as an independent risk factor for ESBL-E colonization among Malagasy women.
“Chereau et al. (2015) identified private indoor access to drinking water (odds ratio (OR) 3.8, 95% CI 1.2-11.6)and living in an individual house (OR 2.2, 95% CI 1.0-4.8)as independent risk factors for ESBL-E colonization among Malagasy women (after adjusting for”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Chereau et al. (2015) source
- Interpretationreasoning
Maternal colonization and/or infection with ESBL-E in pregnant and post-partum women in Africa represents a risk for subsequent neonatal colonization and/or infection with ESBL-E.
“The prevalence of colonization and/or infection with ESBL-E in pregnant and post-partum women in Africa exceeds that reported from high-and middle-income settings, representing a risk for subsequent neonatal colonization and/or infection with ESBL-E.”
Quote in the paperSubstantial claim2 of 3 sources checked- cites Chan et al., 2013 source
The Results (Meta-analyses; page not provided) associate maternal colonization with neonatal colonization, including for E. coli, and the Discussion describes evidence of mother-to-newborn transmission. The paper does not identify ESBL-producing Enterobacteriaceae or establish this specific risk among pregnant or post-partum women in Africa. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites Kaba et al., 2016 source
The Results (poster presentation, p. 196) report ESBL carriage in mothers and infants and clonally related isolates in one mother–infant pair. This is consistent with possible maternal transmission, but the paper does not establish maternal ESBL carriage as a risk factor for subsequent neonatal carriage or infection. It also does not compare prevalence with high- or middle-income settings. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites Rettedal et al., 2015 source
- Findingcitation
Bebell et al. (2017) identified current UTI symptoms (OR 2.5, 95% CI 1.1-6.0, p=0.03) as an independent predictor of ESBL-E infection.
“Bebell et al. ( 2017)) identified single marital status (OR 2.6, 95% CI 1.1-6.1,p = 0.026), low CD4+ count of <200/ml (OR 2.9, 95% CI 1.1-7.7,p = 0.031), and current UTI symptoms (OR 2.5, 95% CI 1.1-6.0,p = 0.03) as independent predictors of ESBL-E infection.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Bebell et al. (2017) source
The Results (Urinary tract infections; page not available) report that 9 of 11 Enterobacteriaceae causing UTIs tested positive for ESBL production, but do not assess current UTI symptoms as an independent predictor of ESBL-E infection. Searches for the stated odds ratio and for a regression analysis found no supporting passage in our copy. (LLM, conf=0.78)
Experimental — accuracy not yet measured
- Findingcitation
Bebell et al. (2017) identified single marital status (OR 2.6, 95% CI 1.1-6.1, p=0.026) as an independent predictor of ESBL-E infection.
“Bebell et al. ( 2017)) identified single marital status (OR 2.6, 95% CI 1.1-6.1,p = 0.026), low CD4+ count of <200/ml (OR 2.9, 95% CI 1.1-7.7,p = 0.031), and current UTI symptoms (OR 2.5, 95% CI 1.1-6.0,p = 0.03) as independent predictors of ESBL-E infection.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Bebell et al. (2017) source
The Results (Enrollment and demographics, Table 1; page unavailable) compare marital status between women with and without confirmed infection, not ESBL-E infection. The Methods (Data entry and statistical analysis; page unavailable) describe group comparisons, and the Results (Urinary tract infections, Table 3; page unavailable) report ESBL findings by bacterial species. Searches for single marital status, OR 2.6, and independent ESBL-E predictors found no passage reporting the claimed association. (LLM, conf=0.76)
Experimental — accuracy not yet measured
- Findingown data
The proportion of ESBL-E colonization was greater than ESBL-E infection.
“In this meta-analysis, the proportion of ESBL-E colonization was found to be greater than ESBL-E infection.”
Quote in the paperSubstantial claim- The authors state this as an assumption: Studies reporting on the magnitude of ESBL-E in pregnant and post-partum women used different laboratory methods, were conducted in different settings (hospital and community), or had other unknown factors influencing the magnitude of ESBL-E in pregnant and post-partum women in Africa.
- Findingown data
The pooled proportion of ESBL-E colonization was 0.19 (95% CI 0.01-0.27).
“The pooled proportion of ESBL-E infections was 0.13 (95% CI 0.01-0.27)compared to 0.19 (95% CI 0.01-0.27)for ESBL-E colonized pregnant and post-partum women (Figure 4).”
Quote in the paperNot a substantial claim- The authors state this as an assumption: Studies reporting on the magnitude of ESBL-E in pregnant and post-partum women used different laboratory methods, were conducted in different settings (hospital and community), or had other unknown factors influencing the magnitude of ESBL-E in pregnant and post-partum women in Africa.
- Findingown data
The overall pooled prevalence of colonization or infection with ESBL-E in pregnant and post-partum women in Africa was 17% (95% CI 10-23%).
“documenting a 17% prevalence of maternal colonization with ESBL-E in Africa (95% CI 10-23%).”
- Also stated in: § Proportion estimates of ESBL-E in pregnant and post-partum women in Africa · plain
“Through meta-analysis of the eligible studies, the overall pooled estimate of the ESBL-E proportion in pregnant and postpartum women in Africa was determined to be 0.17 (95% CI 0.10-0.23)or 17% (95% CI 10-23%) (Figure 2).”
- Also stated in: § Discussion · plain
“This meta-analysis of eligible published studies determined an overall pooled prevalence of colonization or infection with ESBL-E in pregnant and post-partum women in Africa of 17% (95% CI 10-23%).”
Quote in the paperSubstantial claim- The authors state this as an assumption: Studies reporting on the magnitude of ESBL-E in pregnant and post-partum women used different laboratory methods, were conducted in different settings (hospital and community), or had other unknown factors influencing the magnitude of ESBL-E in pregnant and post-partum women in Africa.
- Also stated in: § Proportion estimates of ESBL-E in pregnant and post-partum women in Africa · plain
- Findingcitation
Hospitalization in the last 3 months was not significantly associated with ESBL-E colonization/infection.
“The following elements were not found to be significantly associated with ESBL-E colonization/infection in these three studies: being employed or being a housewife (Tito et al. 2017), drinking water supply from a spring or a well (Chereau et al., 2015), and hospitalization in the last 3 months (Djuikoue et al. 2016a,b).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Djuikoue et al. 2016a,b
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingnone given
Ten observational studies were included for quantitative analysis.
“Ten observational studies were included for quantitative analysis.”
Quote in the paperNot a substantial claim - Findingown data
The pooled proportion of ESBL-E infections was 0.13 (95% CI 0.01-0.27).
“The pooled proportion of ESBL-E infections was 0.13 (95% CI 0.01-0.27)compared to 0.19 (95% CI 0.01-0.27)for ESBL-E colonized pregnant and post-partum women (Figure 4).”
Quote in the paperNot a substantial claim- The authors state this as an assumption: Studies reporting on the magnitude of ESBL-E in pregnant and post-partum women used different laboratory methods, were conducted in different settings (hospital and community), or had other unknown factors influencing the magnitude of ESBL-E in pregnant and post-partum women in Africa.
- Findingown data
The pooled proportion of ESBL-E in post-partum women was 0.07 (95% CI 0.02-0.12).
“The pooled proportion of ESBL-E in pregnant women was 0.22 (95% CI 0.12-0.31)(Figure 2) and that of ESBL-E in post-partum women was 0.07 (95% CI 0.02-0.12).”
Quote in the paperNot a substantial claim- The authors state this as an assumption: Studies reporting on the magnitude of ESBL-E in pregnant and post-partum women used different laboratory methods, were conducted in different settings (hospital and community), or had other unknown factors influencing the magnitude of ESBL-E in pregnant and post-partum women in Africa.
- Findingown data
A total of 1304 participants were pooled from the studies included (927 pregnant women and 377 post-partum women).
“A total of 1304 participants were pooled from the studies included (927 pregnant women and 377 post-partum women).”
Quote in the paperNot a substantial claim - Findingown data
The heterogeneity was high (I2 = 93.6%, p < 0.001).
“The heterogeneity was high (I 2 = 93.6%,p < 0.001).”
Quote in the paperNot a substantial claim - Findingnone given
Data on risk factors for maternal ESBL-E colonization and infection are very limited.
“Data on risk factors for maternal ESBL-E colonization and infection are very limited.”
Quote in the paperNot a substantial claim- Rests on an assumption: The relationship between factors contributing to antimicrobial resistance in Africa and maternal colonization or infection with ESBL-E is unclear and requires investigation.
- Findingown data
The pooled proportion of ESBL-E in community settings was 0.22 (95% CI 0.09-0.34).
“The pooled proportion of ESBL-E in hospital settings was 0.14 (95% CI 0.05-0.23)compared to 0.22 (95% CI 0.09-0.34) in community settings (Figure 3).”
Quote in the paperNot a substantial claim- The authors state this as an assumption: Studies reporting on the magnitude of ESBL-E in pregnant and post-partum women used different laboratory methods, were conducted in different settings (hospital and community), or had other unknown factors influencing the magnitude of ESBL-E in pregnant and post-partum women in Africa.
- Findingcitation
Djuikoue et al. (2016b) found that detection of antimicrobial activity in the stool sample was the only independent risk factor associated with ESBL E. coli carriage in Cameroonian women (OR 5.4, 95% CI 2.0-14.7).
“Djuikoue et al. (2016b)) found that the detection of antimicrobial activity in the stool sample was the only independent risk factor associated with ESBL E. coli carriage in Cameroonian women (OR 5.4, 95% CI 2.0-14.7).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Djuikoue et al. (2016b)
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingown data
The pooled proportion of ESBL-E in community settings exceeded that in hospital settings (22% vs. 14%).
“The prevalence of ESBL-E in community isolates exceeded that in isolates from the hospital setting (22% vs. 14%).”
- Also stated in: § Discussion · plain
“Another important finding is that the pooled proportion of ESBL-E in community settings exceeded that in hospital settings (22% vs. 14%) (Figure 3).”
Quote in the paperSubstantial claim- The authors state this as an assumption: Studies reporting on the magnitude of ESBL-E in pregnant and post-partum women used different laboratory methods, were conducted in different settings (hospital and community), or had other unknown factors influencing the magnitude of ESBL-E in pregnant and post-partum women in Africa.
- Also stated in: § Discussion · plain
- Findingown data
The pooled proportion of ESBL-E in pregnant women was 0.22 (95% CI 0.12-0.31).
“The pooled proportion of ESBL-E in pregnant women was 0.22 (95% CI 0.12-0.31)(Figure 2) and that of ESBL-E in post-partum women was 0.07 (95% CI 0.02-0.12).”
Quote in the paperNot a substantial claim- The authors state this as an assumption: Studies reporting on the magnitude of ESBL-E in pregnant and post-partum women used different laboratory methods, were conducted in different settings (hospital and community), or had other unknown factors influencing the magnitude of ESBL-E in pregnant and post-partum women in Africa.
- Findingown data
The pooled proportion of ESBL-E was higher among pregnant women than post-partum women (22% vs. 7%).
“The pooled proportion of ESBL-E was higher among pregnant women than post-partum women (22% vs. 7%) (Figure 2).”
Quote in the paperSubstantial claim- The authors state this as an assumption: Studies reporting on the magnitude of ESBL-E in pregnant and post-partum women used different laboratory methods, were conducted in different settings (hospital and community), or had other unknown factors influencing the magnitude of ESBL-E in pregnant and post-partum women in Africa.
- Findingown data
The pooled proportion of ESBL-E in hospital settings was 0.14 (95% CI 0.05-0.23).
“The pooled proportion of ESBL-E in hospital settings was 0.14 (95% CI 0.05-0.23)compared to 0.22 (95% CI 0.09-0.34) in community settings (Figure 3).”
Quote in the paperNot a substantial claim- The authors state this as an assumption: Studies reporting on the magnitude of ESBL-E in pregnant and post-partum women used different laboratory methods, were conducted in different settings (hospital and community), or had other unknown factors influencing the magnitude of ESBL-E in pregnant and post-partum women in Africa.
- Findingown data
The most frequently reported ESBL-encoding gene was CTX-M.
“The most frequently reported ESBL-encoding gene was CTX-M (cefotaxime hydrolyzing capabilities).”
Quote in the paperNot a substantial claim - Findingcitation
Being employed or being a housewife was not significantly associated with ESBL-E colonization/infection.
“The following elements were not found to be significantly associated with ESBL-E colonization/infection in these three studies: being employed or being a housewife (Tito et al. 2017), drinking water supply from a spring or a well (Chereau et al., 2015), and hospitalization in the last 3 months (Djuikoue et al. 2016a,b).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Tito et al. 2017
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingown data
The number of eligible studies was small.
“The number of eligible studies was small, demonstrating the apparent lack of studies on ESBL-E colonization and infection in this population group: pregnant and post-partum women in Africa.”
Quote in the paperSubstantial claim - Findingown data
There is an apparent lack of studies on ESBL-E colonization and infection in pregnant and post-partum women in Africa.
“The number of eligible studies was small, demonstrating the apparent lack of studies on ESBL-E colonization and infection in this population group: pregnant and post-partum women in Africa.”
Quote in the paperSubstantial claim - Findingnone given
In African pregnant and post-partum women, the prevalence of ESBL-E in community isolates exceeds that in hospital isolates.
“In African pregnant and post-partum women, the prevalence of ESBL-E in community isolates exceeds that in hospital isolates.”
Quote in the paperNot a substantial claim - Findingnone given
The level of colonization and/or infection with ESBL-E in pregnant and post-partum women in Africa is higher than that reported from high- and middle-income settings.
“The level of colonization and/or infection with ESBL-E in pregnant and post-partum women in Africa is higher than that reported from high-and middle -income settings.”
Quote in the paperNot a substantial claim - Interpretationcitation
The clinical significance of increased ESBL-E-associated UTI during pregnancy is the potential for adverse pregnancy and neonatal outcomes, including intrauterine growth restriction, low birth weight, premature rupture of the membranes, foetal death, and neonatal infections.
“The clinical significance of increased ESBL-E-associated UTI during pregnancy is the potential for adverse pregnancy and neonatal outcomes, including intrauterine growth restriction, low birth weight, premature rupture of the membranes, foetal death, and neonatal infections (Loh and Sivalingam., 2007;Romero et al., 1989;Ovalle and Levancini, 2001;Matuszkiewicz-Rowi nska et al., 2015).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Loh and Sivalingam., 2007
- cites Romero et al., 1989
- cites Ovalle and Levancini, 2001 source
- Interpretationcitation
The pooled ESBL-E rate documented herein is in line with a well-powered systematic review conducted in Africa by Tansarli et al. (2014), who reported proportions varying from 1.5% to 22.8% among patients either infected or colonized with Enterobacteriaceae.
“This rate of colonization or infection with ESBL-E is in line with a well-powered systematic review conducted in Africa by Tansarli et al. (2014), who reported proportions varying from 1.5% to 22.8% (pooled from 13 studies with isolates from clinical urine samples) among patients either infected or colonized with Enterobacteriaceae.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Tansarli et al. (2014) source
- Interpretationown data
The prevalence of colonization and/or infection with ESBL-E in pregnant and post-partum women in Africa exceeds that reported from high- and middle-income settings.
“The prevalence of colonization and/or infection with ESBL-E in pregnant and post-partum women in Africa exceeds that reported from high-and middle-income settings, representing a risk for subsequent neonatal colonization and/or infection with ESBL-E.”
- Also stated in: § Discussion · plain
“The pooled ESBL-E rate documented herein is substantially higher than the rates found in high-and middleincome countries, e.g., Norway (2.9%) (Rettedal et al., 2015) and Argentina (5.4%) (Villar et al., 2013).”
Quote in the paperSubstantial claim0 of 2 sources checked - Also stated in: § Discussion · plain
- Interpretationreasoning
The findings of this systematic review and meta-analysis may not be generalizable to all pregnant and/or post-partum women in Africa.
“Given the limited sample size, the findings of this systematic review and meta-analysis may not be generalizable to all pregnant and/or post-partum women in Africa.”
Quote in the paperSubstantial claim - Interpretationreasoning
The finding that community ESBL-E proportions exceeded hospital proportions may have been influenced by the high prevalence of ESBL-E in community isolates (58%) in the Cameroonian study.
“This finding may have been influenced by the high prevalence of ESBL-E in community isolates (58%) in the Cameroonian study.”
Quote in the paperSubstantial claim - Study design and conductnone given
The publications retrieved and included in the meta-analysis were all observational studies.
“The publications retrieved and included in the meta-analysis were all observational studies, a study type that is prone to many biases, including selection and information biases (Archer and Horn, 2006).”
Quote in the paperSubstantial claim - Interpretationcitation
The detection of ESBL-E in samples from hospitalized pregnant women with short lengths of stay may represent community-acquired colonization and/or infection with ESBL-E.
“The detection of ESBL-E in samples from hospitalized pregnant women with short lengths of stay may represent communityacquired colonization and/or infection with ESBL-E.”
Quote in the paperNot a substantial claim - Interpretationreasoning
The apparent difference in ESBL-E proportions between community and hospital settings could also be explained by the fact that all included studies from the community only studied ESBL-E colonization.
“The apparent difference in ESBL-E proportions between community and hospital settings could also be explained by the fact that all included studies from the community only studied ESBL-E colonization.”
Quote in the paperNot a substantial claim
- Classified as probably not a substantial claim. 16
- May combine two claims. 3
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationThe Freeman-Tukey arcsine methodology was applied to ensure proportionate weight distribution to studies presenting extreme prevalence.
“To ensure proportionate weight distribution to studies presenting extreme prevalence (near 0 or 1), the Freeman-Tukey arcsine methodology was applied (Nyaga et al., 2014).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Nyaga et al., 2014 source
The Results (Example two; page not provided) use the Freeman–Tukey transformation when some proportions are at or near 1, explaining that studies at 1 would otherwise be excluded and bias the pooled estimate. The Methods describe a weighted pooled estimate after transformation, but do not say the method ensures proportionate weight distribution to studies with extreme prevalence. (LLM, conf=0.84)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
InterpretationcitationBecause ESBL-E stool carriage persists for a variable length of time, the study population may have acquired ESBL-E during pregnancy that then persisted up to delivery and the post-partum period, reflecting community-acquired antimicrobial resistance genes rather than healthcare-associated acquisition.
“Because ESBL-E stool carriage persists for a variable length of time (Ahmed et al., 2014), the study population may have acquired ESBL-E during pregnancy that then persisted up to delivery and the post-partum period, reflecting community-acquired antimicrobial resistance genes rather than healthcare-associated acquisition.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Ahmed et al., 2014 source
Split into 2 atoms — 1 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 1 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S4 (based).
Findingnone givenThis appears to be the first systematic review and meta-analysis on ESBL-E colonization and/or infection focusing on pregnant and post-partum women in Africa.
“This appears to be the first systematic review and meta-analysis on ESBL-E colonization and/or infection focusing on pregnant and post-partum women in Africa.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenResearch on determinants of maternal colonization in Africa is scarce.
“However, the scarcity of research on determinants of maternal colonization in Africa is worrisome.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductown dataA random-effects meta-analysis was performed to summarize the proportions and 95% confidence intervals of ESBL-E in pregnant or post-partum women in Africa.
“A random-effects meta-analysis was performed to summarize the proportions and the 95% confidence intervals (CI) of ESBL-E in pregnant or post-partum women in Africa.”
Quote in the paperSubstantial claim- The authors state this as an assumption: Studies reporting on the magnitude of ESBL-E in pregnant and post-partum women used different laboratory methods, were conducted in different settings (hospital and community), or had other unknown factors influencing the magnitude of ESBL-E in pregnant and post-partum women in Africa.
Classified as probably not a substantial claim. May combine two claims.
Study design and conductnone givenA comprehensive search of several electronic databases was performed, in addition to manual searches and attempts to contact authors of relevant studies to obtain specific details.
“A comprehensive search of several electronic databases was performed, in addition to manual searches and attempts to contact authors of relevant studies to obtain specific details.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationThis meta-analysis of observational studies is reported in compliance with the MOOSE statement and checklist.
“This meta-analysis of observational studies is reported in compliance with the MOOSE statement and checklist (Stroup et al., 2000) (Meta-analysis of Observational Studies in Epidemiology).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Stroup et al., 2000 source
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationThe between-study heterogeneity was assessed using the I2 statistic.
“The between-study heterogeneity was assessed using the I 2 statistic (which quantifies the percentage of variation across studies due to heterogeneity rather than to chance): I 2 <75% was considered as moderate heterogeneity (Higgins and Thompson, 2002) and >75% reflected high heterogeneity, in which case subset analyses were performed.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Higgins and Thompson, 2002 source
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoningThe authors made an effort to search the grey literature by using Google Scholar.
“The authors made an effort to search the 'grey literature' by using Google Scholar, as many African publications are not listed in PubMed or Scopus.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationThe Newcastle-Ottawa Scale adapted for cross-sectional studies was used to assess the risk of bias for each selected study.
“The Newcastle-Ottawa Scale (Herzog et al., 2013) adapted for cross-sectional studies (see below) was used to assess the risk of bias for each selected study.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Herzog et al., 2013
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Classified as probably not a substantial claim.
Study design and conductnone givenStudies with a minimum score of 3 were considered of acceptable methodological quality for inclusion in the meta-analysis.
“Studies with a minimum score of 3 were considered of acceptable methodological quality for inclusion in the meta-analysis (Table 2).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationcitationThe difference in ESBL-E proportions between pregnant and post-partum women may be explained by a greater probability of UTIs with ESBL-E during pregnancy than in the post-partum period.
“This difference may be explained by a greater probability of UTIs with ESBL-E during pregnancy than in the post-partum period (Sáezlópez et al., 2016).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Sáezlópez et al., 2016
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Study design and conductnone givenEach study was thoroughly assessed for risk of bias.
“Each study was thoroughly assessed for risk of bias.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationcitationLack of trained healthcare workers and weak laboratory and infection control capacity may contribute to healthcare-associated transmission of ESBL-E to pregnant and post-partum women.
“Another possible explanation is that the lack of trained healthcare workers (Kimang'a, 2012) and weak laboratory and infection control capacity (Petti et al., 2006) may contribute to healthcare-associated transmission of ESBL-E to pregnant and post-partum women.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Kimang'a, 2012
- cites Petti et al., 2006 source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationObservational studies are prone to many biases, including selection and information biases.
“The publications retrieved and included in the meta-analysis were all observational studies, a study type that is prone to many biases, including selection and information biases (Archer and Horn, 2006).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Archer and Horn, 2006
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S4 (based). May combine two claims.
Interpretationnone givenMaternal ESBL-E colonization/infection represents a risk for mother-to-child pathogen transmission with the potential for subsequent neonatal colonization and/or infection.
“Maternal ESBL-E colonization/infection represents a risk for mother to child pathogen transmission with the potential for subsequent neonatal colonization and/or infection.”
Quote in the paperNot a substantial claim
The authors state this as an assumption.
Studies reporting on the magnitude of ESBL-E in pregnant and post-partum women used different laboratory methods, were conducted in different settings (hospital and community), or had other unknown factors influencing the magnitude of ESBL-E in pregnant and post-partum women in Africa.
“The randomeffects model was chosen based on the anticipated assumption that studies reporting on the magnitude of ESBL-E in pregnant and post-partum women used different laboratory methods, were conducted in different settings (hospital and community), or had other unknown factors influencing the magnitude of ESBL-E in pregnant and post-partum women in Africa.”
The paper relies on this without support.
The relationship between factors contributing to antimicrobial resistance in Africa and maternal colonization or infection with ESBL-E is unclear and requires investigation.
“The relationship between these factors and maternal colonization or infection with ESBL-E is unclear and requires investigation.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Conflicting counts of pregnant and post-partum studies
MinorThe abstract assigns seven studies to pregnant women and three to post-partum women, while the Results section assigns six and four, respectively.
“Ten studies (seven on pregnant women and three on post-partum women) were included”
“Six studies reported on pregnant women and four on post-partum women.”
Infection confidence-interval lower bound differs from Figure 4
MinorThe text gives 0.01 as the lower bound for the pooled infection estimate, but Figure 4 gives -0.01.
“The pooled proportion of ESBL-E infections was 0.13 (95% CI 0.01-0.27)”
“0.13 (-0.01, 0.27 )”
Colonization confidence-interval lower bound differs from Figure 4
MinorThe text gives 0.01 as the lower bound for the pooled colonization estimate, but Figure 4 gives 0.10.
“0.19 (95% CI 0.01-0.27)for ESBL-E colonized pregnant and post-partum women”
“0.19 (0.10 , 0.27)”
Cites
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763 · see citing works
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623 · see citing works
Extended-Spectrum β-Lactamases: a Clinical Update
Paterson, D. L., & Bonomo, R. A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.4.657-686.2005 · Cited by 3,495 · see citing works
Metaprop: a Stata command to perform meta-analysis of binomial data
Nyaga, V. N., Arbyn, M., & Aerts, M. (2014) · Archives of Public Health · doi:10.1186/2049-3258-72-39 · Cited by 2,139 · see citing works
CTX-M: changing the face of ESBLs in Europe
Livermore, D. M., Cantón, R., Gniadkowski, M., Nordmann, P., Rossolini, G. M., Arlet, G., Ayala, J. A., Coque, T. M., Kern-Zdanowicz, I., Luzzaro, F., et al. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl483 · Cited by 927 · see citing works
Hospital-acquired neonatal infections in developing countries
Zaidi, A. K., Huskins, W. C., Thaver, D., Bhutta, Z. A., Abbas, Z., & Goldmann, D. A. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71881-x · Cited by 830 · see citing works
Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community
Pitout, J. D. D., Nordmann, P., Laupland, K. B., & Poirel, L. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki166 · Cited by 790 · see citing works
Laboratory medicine in Africa: a barrier to effective health care
Petti, C. A., Polage, C. R., Quinn, T. C., Ronald, A. R., & Sande, M. A. (2006) · Clinical Infectious Diseases · doi:10.1086/499363 · Cited by 749 · see citing works
Okeke, I. N., Lamikanra, A., & Edelman, R. (1999) · Emerging infectious diseases · doi:10.3201/eid0501.990103 · Cited by 650 · see citing works
Bain, R., Cronk, R., Wright, J., Yang, H., Slaymaker, T., & Bartram, J. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001644 · Cited by 619 · see citing works
(1989) · PubMed · Cited by 444 · see citing works
Peirano, G., & Pitout, J. D. D. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.11.003 · Cited by 443 · see citing works
Kim, Y. K., Pai, H., Lee, H. J., et al. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.5.1481-1491.2002 · Cited by 357 · see citing works
Public health impact of Rwandan refugee crisis: what happened in Goma, Zaire, in July, 1994?
Goma Epidemiology Group (1995) · The Lancet · doi:10.1016/s0140-6736(95)90338-0 · Cited by 332 · see citing works
Kang, C., Kim, S., Park, W. B., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4574-4581.2004 · Cited by 267 · see citing works
Chan, G. J., Lee, A. C., Baqui, A. H., Tan, J., & Black, R. E. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001502 · Cited by 253 · see citing works
Schiappa, D. A., Hayden, M. K., Matushek, M. G., Hashemi, F. N., Sullivan, J., Smith, K. Y., Miyashiro, D. K., Quinn, J. P., Weinstein, R. A., & Trenholme, G. M. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/174.3.529 · Cited by 244 · see citing works
Matuszkiewicz‐Rowińska, J., Małyszko, J., & Wieliczko, M. (2015) · Archives of Medical Science · doi:10.5114/aoms.2013.39202 · Cited by 233 · see citing works
Blomberg, B., Jureen, R., Manji, K. P., Tamim, B. S., Mwakagile, D., Urassa, W. K., Fataki, M. R., Msangi, V., Tellevik, M. G., Maselle, S. Y., et al. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.2.745-749.2005 · Cited by 226 · see citing works
Urinary Tract Infections in Pregnancy
Mittal, P., & Wing, D. A. (2005) · Clinics in Perinatology · doi:10.1016/j.clp.2005.05.006 · Cited by 170 · see citing works
Zaoutis, T. E., Goyal, M., Chu, J. H., et al. (2005) · PEDIATRICS · doi:10.1542/peds.2004-1289 · Cited by 155 · see citing works
Antimicrobial resistance in the WHO African region: current status and roadmap for action
Essack, S. Y., Desta, A., Abotsi, R. E., & Agoba, E. E. (2016) · Journal of Public Health · doi:10.1093/pubmed/fdw015 · Cited by 138 · see citing works
Aljabri, K. S., Somoa, B., & Khan, M. J. (2010) · Annals of Saudi Medicine · doi:10.4103/0256-4947.72265 · Cited by 131 · cited 1× · see citing works
“Five studies (Nelson et al., 2014; Olufunke et al., 2014; Aljabri et al., 2010; Bebell et al., 2017; Tito et al., 2017), detected ESBL production using the double disc synergy test (DDST).”
MethodLogan, L. K., Braykov, N. P., Weinstein, R. A., et al. (2014) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piu010 · Cited by 130 · see citing works
Ntirenganya, C., Manzi, O., Muvunyi, C. M., & Ogbuagu, O. E. (2015) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.14-0607 · Cited by 129 · see citing works
Antibacterial resistance in sub‐Saharan Africa: an underestimated emergency
Kariuki, S., & Gordon Dougan, B. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12380 · Cited by 122 · see citing works
Antimicrobial resistance — A ticking bomb!
Yewale, V. N. (2014) · Indian Pediatrics · doi:10.1007/s13312-014-0374-3 · Cited by 116 · see citing works
Flokas, M. E., Karanika, S., Alevizakos, M., & Mylonakis, E. E. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171216 · Cited by 109 · see citing works
URINARY TRACT INFECTIONS IN PREGNANCY
Connolly, A., & Thorp, J. M. (1999) · Urologic Clinics of North America · doi:10.1016/s0094-0143(05)70218-4 · Cited by 106 · see citing works
Denkel, L. A., Schwab, F., Kola, A., Leistner, R., Garten, L., von Weizsacker, K., Geffers, C., Gastmeier, P., & Piening, B. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku097 · Cited by 105 · see citing works
Trends in paediatric bloodstream infections at a South African referral hospital
Dramowski, A., Cotton, M. F., Rabie, H., & Whitelaw, A. C. (2015) · BMC Pediatrics · doi:10.1186/s12887-015-0354-3 · Cited by 104 · see citing works
Self-citationSonda, T., Kumburu, H. H., van Zwetselaar, M., Alifrangis, M., Lund, O., Kibiki, G. S., & Aarestrup, F. M. (2016) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-016-0117-4 · Cited by 96 · see citing works
Pallecchi, L., Malossi, M., Mantella, A., Gotuzzo, E., Trigoso, C., Bartoloni, A., Paradisi, F., Kronvall, G., & Rossolini, G. M. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4556-4561.2004 · Cited by 94 · see citing works
Chan, G. J., Lee, A. C., Baqui, A. H., et al. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-0813-3 · Cited by 88 · see citing works
Tansarli, G. S., Poulikakos, P., Kapaskelis, A., & Falagas, M. E. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt500 · Cited by 87 · see citing works
Storberg, V. (2014) · Infection Ecology & Epidemiology · doi:10.3402/iee.v4.20342 · Cited by 86 · see citing works
Urinary tract infections in pregnancy
Ovalle, A., & Levancini, M. (2001) · Current Opinion in Urology · doi:10.1097/00042307-200101000-00008 · Cited by 86 · see citing works
Antimicrobial-resistant infections among postpartum women at a Ugandan referral hospital
Bebell, L. M., Ngonzi, J., Bazira, J., Fajardo, Y., Boatin, A. A., Siedner, M. J., Bassett, I. V., Nyehangane, D., Nanjebe, D., Jacquemyn, Y., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0175456 · Cited by 86 · see citing works
A situational analysis of antimicrobial drug resistance in Africa: are we losing the battle?
(2012) · Europe PMC (PubMed Central) · Cited by 82 · see citing works
Nair, N. P., Chalmers, L., Connolly, M., Bereznicki, B. J., Peterson, G. M., Curtain, C. M., Castelino, R. L., & Bereznicki, L. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165757 · Cited by 79 · see citing works
Dondzilo, L., Rieger, E., Palermo, R., Byrne, S. M., & Bell, J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177870 · Cited by 70 · see citing works
Rettedal, S., Löhr, I. H., Bernhoff, E., Natås, O. B., Sundsfjord, A., & Øymar, K. (2015) · Journal of Perinatology · doi:10.1038/jp.2015.82 · Cited by 66 · see citing works
Pierce, M. M. (2015) · AccessScience · doi:10.1036/1097-8542.br0817152 · Cited by 65 · see citing works
Ahmed, S., Ali, M. M. M., Mohamed, Z., Moussa, T. A., & Klena, J. D. (2014) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-13-22 · Cited by 64 · see citing works
Chereau (2015) · doi:10.1128/aac.00029-15 · Cited by 61 · see citing works
Sáez-López, E., Guiral, E., Fernández‐Orth, D., Villanueva, S., Goncé, A., López, M., Teixidó, I., Pericot, A., Figueras, F., Palacio, M., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146531 · Cited by 60 · see citing works
Ndir, A., Diop, A., Faye, P. M., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0143729 · Cited by 54 · see citing works
Urinary Tract Infections in Pregnancy
Forman, E. J., & Gabbur, N. (2006) · Obstetrics and Gynecology · doi:10.1097/00006250-200604001-00161 · Cited by 53 · see citing works
Luvsansharav, U.-O., Hirai, I., Niki, M., Sasaki, T., Makimoto, K., Komalamisra, C., Maipanich, W., Kusolsuk, T., Sanguankiat, S., Pubampen, S., et al. (2011) · Journal of Medical Microbiology · doi:10.1099/jmm.0.026955-0 · Cited by 48 · see citing works
Urinary tract infections in pregnancy.
(2007) · Europe PMC (PubMed Central) · Cited by 48 · see citing works
Nelson, E. C., Kayega, J., Seni, J., Mushi, M. F., Kidenya, B. R., Hokororo, A., Zuechner, A., Kihunrwa, A., & Mshana, S. E. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-279 · Cited by 46 · see citing works
Villar, H. E., Aubert, V., Baserni, M. N., & Jugo, M. B. (2013) · Journal of Chemotherapy · doi:10.1179/1973947813y.0000000081 · Cited by 36 · see citing works
Chaula, T., Seni, J., Ng’walida, N., et al. (2017) · International Journal of Microbiology · doi:10.1155/2017/4042686 · Cited by 33 · see citing works
Infection control in developing countries with particular emphasis on South Africa
Duse, A. G. (2005) · Southern African Journal of Epidemiology and Infection · doi:10.1080/10158782.2005.11441230 · Cited by 31 · see citing works
Fortini, D., Fashae, K., Villa, L., et al. (2014) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2014.12.002 · Cited by 31 · see citing works
Boushey, C. J., Harris, J. E., Bruemmer, B., et al. (2006) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2005.11.007 · Cited by 31 · see citing works
Djuikoue, C. I., Woerther, P., Toukam, M., et al. (2016) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.7616 · Cited by 30 · see citing works
Onwuezobe, A., & Orok, F. E. (2015) · African Journal of Clinical and Experimental Microbiology · doi:10.4314/ajcem.v16i2.1 · Cited by 17 · see citing works
Mizumoto, B. R., Moreira, B. M., Santoro‐Lopes, G., et al. (2015) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2015.02.003 · Cited by 14 · see citing works
Olufunke, O. A., Aregbesola, O. A., & Fashina, C. D. (2014) · Journal of Molecular Biology Research · doi:10.5539/jmbr.v4n1p34 · Cited by 13 · see citing works
Kaba, M., Manenzhe, R. I., Moodley, C., Zar, H. J., & Nicol, M. P. (2016) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2016.02.254 · Cited by 9 · see citing works
Emacar, J., Okemo, P. O., Gatheri, G. W., et al. (2010) · Kenyatta University Institutional Repository (Kenyatta University) · Cited by 7 · see citing works
Vullo, S., Purpari, G., Chiarenza, G. L., et al. (2016) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2016.02.654 · Cited by 2 · see citing works
Trends of acute watery diarrhea in Lao People's Democratic Republic, 2009-2013
Houadthongkham, S., Jennings, G. J., Sithivong, N., et al. (2016) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2016.02.655 · Cited by 2 · see citing works
Flagged first, then by citations
Research works printed but not linked: 4
- Aljabri, 2010, Original article, Ann Saudi Med, 30, 10
- Archer, 2006, Perspectives in practice publishing nutrition research: a review of 2006, J Am Diet Assoc, 4, 89
- Frieden, 2013, Antibiotic resistance threats, CDC, 22
- Lincetto, 2006, Antenatal care, Lancet, 51
Cited by
Sorted by citations
Onduru, O. G., Mkakosya, R. S., Aboud, S., & Rumisha, S. F. (2021) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2021/5153237 · Cited by 59 · see citing works
Healthcare-Associated Infection Prevention Interventions for Neonates in Resource-Limited Settings
Dramowski, A., Aucamp, M., Beales, E. R., Bekker, A., Cotton, M. F., Fitzgerald, F., Labi, A.-K., Russell, N., Strysko, J. P., Whitelaw, A. C., et al. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.919403 · Cited by 53 · see citing works
“Advocacy for Infection Prevention and Surveillance Programs in LMIC Neonatal Units Low- and middle-income countries’ neonatal units face many challenges, such as inadequate financing, understaffing, aging infrastructure, and the lack of effective leadership (8).”
BackgroundSelf-citationEarly-versus late-onset sepsis in neonates – time to shift the paradigm?
Russell, N., Barday, M., Okomo, U. A., Dramowski, A., Sharland, M., & Bekker, A. (2023) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2023.07.023 · Cited by 50 · see citing works
Self-citationPuspandari, N., Sunarno, S., Febrianti, T., et al. (2021) · One Health · doi:10.1016/j.onehlt.2021.100331 · Cited by 48 · see citing works
“coli in pregnant women was high in several African countries, especially Cameroon (57%) [13].”
BackgroundKuralayanapalya, S. P., Patil, S. S., Hamsapriya, S., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0221771 · Cited by 47 · see citing works
Bulabula, A. N. H., Dramowski, A., & Mehtar, S. (2019) · Journal of Hospital Infection · doi:10.1016/j.jhin.2019.10.001 · Cited by 44 · see citing works
Self-citationHigh Prevalence of Cefotaxime Resistant Bacteria in Grazing Beef Cattle: A Cross Sectional Study
Markland, S. M., Weppelmann, T. A., Ma, Z., Lee, S.-Y., Mir, R. A., Teng, L., Ginn, A., Lee, C., Ukhanova, M., Galindo, S., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00176 · Cited by 40 · see citing works
“In 2017, the World Health Organization (WHO) identified that ESBLproducing Enterobacteriaceae as one of the priority pathogens included in a catalog of 12 families of bacteria (Bulabula et al., 2017).”
BackgroundMannathoko, N. B., Mosepele, M., Gross, R., et al. (2022) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2022.06.004 · Cited by 33 · see citing works
Wolf, M. F., Shqara, R. A., Naskovica, K., Zilberfarb, I. A., Sgayer, I., Glikman, D., Rechnitzer, H., Sheffer, V. F., & Bornstein, J. (2021) · Microorganisms · doi:10.3390/microorganisms9030506 · Cited by 27 · see citing works
“The ESBL-E-carriage rate of our study populatio was comparable to that reported in Africa [14,16] and substantially higher than that observed in high- and middleincome countries, e.”
BackgroundResultMansouri, F., Sheibani, H., Javedani Masroor, M., & Afsharian, M. (2019) · International Journal of Clinical Practice · doi:10.1111/ijcp.13422 · Cited by 26 · see citing works
Ghaddar, N., Anastasiadis, E., Halimeh, R., et al. (2020) · Infectious Diseases in Obstetrics and Gynecology · doi:10.1155/2020/4190306 · Cited by 25 · see citing works
“EOS are Streptococcus agalactiae and Escherichia coli [1, 2].”
BackgroundSharma, A., Luvsansharav, U. O., Paul, P., Lutgring, J. D., Call, D. R., Omulo, S., Laserson, K., Rafael Araos, B., Munita, J. M., Verani, J. R., et al. (2021) · BMC Public Health · doi:10.1186/s12889-021-11451-y · Cited by 26 · see citing works
Innovation for infection prevention and control—revisiting Pasteur's vision
Birgand, G., Ahmad, R., Bulabula, A. N. H., Singh, S. K., Bearman, G. M., Castro‐Sánchez, E., & Holmes, A. H. (2022) · The Lancet · doi:10.1016/s0140-6736(22)02459-x · Cited by 23 · see citing works
Self-citationLautenbach, E., Mosepele, M., Smith, R. M., et al. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad259 · Cited by 20 · see citing works
Kiros, T., Workineh, L., Tiruneh, T., et al. (2021) · International Journal of Microbiology · doi:10.1155/2021/6669778 · Cited by 18 · see citing works
“[60] that was 14% (95% CI: 8–21) and a study in Africa that reported 17% (95% CI: 10–23) [35].”
Bulabula, A. N. H., Dramowski, A., & Mehtar, S. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz427 · Cited by 16 · see citing works
Self-citationMusa, B. M., Imam, H., Lendel, A., et al. (2019) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1093/trstmh/trz125 · Cited by 16 · see citing works
Abay, G. K., Shfare, M. T., Gebrecherkos, T., et al. (2025) · European journal of medical research · doi:10.1186/s40001-024-02267-8 · Cited by 15 · see citing works
Mwandigha, A. M., Kamori, D., Kibwana, U. O., Masoud, S. S., Manyahi, J., & Majigo, M. V. (2020) · Tropical Medicine and Health · doi:10.1186/s41182-020-00271-2 · Cited by 13 · see citing works
Neemann, K., Olateju, E. K., Izevbigie, N., Akaba, G. O., Olanipekun, G. M., Richard, J. C., Duru, C., Kocmich, N. J., Samson, K. K., Rezac-Elgohary, A., et al. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.07.013 · Cited by 12 · see citing works
Blumenröder, S., Wilson, D., Ndaboine, E., Mirambo, M. M., Mushi, M. F., Bader, O., Zimmermann, O., Mshana, S. E., & Groß, U. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1171651 · Cited by 12 · see citing works
Obeng‐Nkrumah, N., Korang-Labi, A., Kwao, P., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0310058 · Cited by 11 · see citing works
Fiseha, S. B., Mulatu, G., Azerefegn, E., et al. (2021) · Infection and Drug Resistance · doi:10.2147/idr.s326200 · Cited by 11 · see citing works
Carbapenem-producing Enterobacteriaceae in mothers and newborns in southeast Gabon, 2022
Santos, S. D., Moussounda, M., Togola, M., et al. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1341161 · Cited by 9 · see citing works
Jalilian, N., Kooshkiforooshani, M., Ahmadi, S., & Nankali, A. (2019) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2019.06.010 · Cited by 8 · see citing works
Kiros, T., Belete, D., Andualem, T., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e20072 · Cited by 8 · see citing works
“The variation of the present study with the previously done result may be due to the difference in the study design, study population (community-onset and/or hospitalized carriage) and the sample size [3,14,55,56].”
Resultde Lauzanne, A., Sreng, N., Foucaud, E., Touch, S., Chon, T., Yem, C., Hak, V., Heng, S., Meng, S., Gouali, M., et al. (2022) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkac224 · Cited by 7 · see citing works
Sgayer, I., Glikman, D., Shqara, R. A., Maimon, M., Rechnitzer, H., Lowenstein, L., & Wolf, M. F. (2022) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.14555 · Cited by 5 · see citing works
Sowden, M., van Niekerk, E., Bulabula, A. N. H., Dramowski, A., Whitelaw, A. C., Twisk, J. W. R., & van Weissenbruch, M. M. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.1002762 · Cited by 7 · see citing works
Self-citationYounis, N. K. (2024) · Iraqi Journal of Science · doi:10.24996/ijs.2024.65.1.3 · Cited by 6 · see citing works
Nana, T., Bhoora, S., & Chibabhai, V. (2021) · Southern African Journal of Infectious Diseases · doi:10.4102/sajid.v36i1.328 · Cited by 6 · see citing works
Shimeles, G., Gedefie, A., Motbainor, H., & Genet, C. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1475357 · Cited by 5 · see citing works
Sulikah, S. R. O., Hasanah, M., Setyarini, W., Parathon, H., Kitagawa, K., Nakanishi, N., Nomoto, R., Osawa, K., Kinoshita, S., Hirai, I., et al. (2021) · Microbial Drug Resistance · doi:10.1089/mdr.2020.0506 · Cited by 8 · see citing works
“20,21 In the present study, we investigated the occurrence of ESBL-E fecal carriage among 200 pregnant women who visited a primary health center (PHC, 101 women) or were admitted to the hospitals (99 women) in Surabaya, Indonesia from July to October 2018 and identified the phenotypic and genotypic…”
Said, M. M., Msanga, D. R., Mtemisika, C. I., Silago, V., Mirambo, M. M., & Mshana, S. E. (2022) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed7080144 · Cited by 5 · see citing works
“Low parent educational attainment is associated with low socioeconomic status, which has been associated with sub-optimal hygiene, which favors the emergence and spreading of ESBL-PE, as previously reported [19,40].”
ResultNjeuna, A., Founou, L. L., Founou, R. C., et al. (2024) · American Journal of Infection Control · doi:10.1016/j.ajic.2024.06.002 · Cited by 4 · see citing works
Huang, D. J., Hösli, I., Tschudin‐Sutter, S., Pfister, T., Granado, C., Müller-Borer, D., Schötzau, A., Frei, R., Dangel, M., Huhn, E. A., et al. (2019) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2019.07.024 · Cited by 4 · see citing works
Aoutil, N., Cherkaoui, M., & Bouskraoui, M. (2025) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-025-08089-8 · Cited by 3 · see citing works
Enterobacter cloacae Complex Meningitis in a Full-term Neonate
Pallitto, C. R., Feuerstein, J. L., Baer, A. Z., et al. (2023) · Clinical Pediatrics · doi:10.1177/00099228231155391 · Cited by 3 · see citing works
Obadare, T. O., Adeyemo, A. T., Odetoyin, B., et al. (2023) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1093/trstmh/trad010 · Cited by 3 · see citing works
Emekekwue, A. S., Ugwu, M. C., Ejikeugwu, C. P., et al. (2022) · International Journal of Pharmaceutical and Phytopharmacological Research · doi:10.51847/x5e62apemi · Cited by 3 · see citing works
Olorunleke, S. O., Kirchner, M. J., Duggett, N. A., Stevens, K., Chah, K. F., Nwanta, J. A., Brunton, L. A., & Anjum, M. F. (2024) · PLoS ONE · doi:10.1371/journal.pone.0289190 · Cited by 2 · see citing works
Jang, W.-K., & Bae, J. G. (2021) · Antibiotics · doi:10.3390/antibiotics10080933 · Cited by 2 · see citing works
“In particular, if there is a cervical colonization of multidrug-resistant bacteria, this can be transmitted to neonates during delivery [33], as shown in the results of this study.”
ResultOktaviani, R., Hasanah, M., Setyarini, W., et al. (2020) · doi:10.21203/rs.3.rs-38906/v1 · Cited by 2 · see citing works
“Surprisingly, a systemic review and meta-analysis of the prevalence of ESBL-E carriage among pregnant and post-partum women in Africa revealed that the prevalence of maternal carriage of ESBL-E in the community exceeded that in hospitals (22% versus 14%) (20, 21).”
BackgroundEmergence of ST1193 Clone in Maternal and Neonatal ESBL-Producing E. coli Isolates
Ling, W., Chen, Q., Yang, L., et al. (2023) · Infection and Drug Resistance · doi:10.2147/idr.s418455 · Cited by 1 · see citing works
“Maternal colonization with ESBL-EC is considered as a significant risk factor for the acquisition of neonatal infection.(8,9) Fecal carriage of ESBL-EC is an important reservoir for the transmission and dissemination of infection with resistant strains.”
BackgroundAshton, F., Bekker, A., Aucamp, M., et al. (2025) · Antibiotics · doi:10.3390/antibiotics14040392 · Cited by 1 · see citing works
“As levels of ESBL infection and colonisation have been shown to be high in pregnant women in Africa [27], the prevention of maternal colonisation and infection is an important area to address, to prevent neonatal colonisation and infection with antibiotic-resistant organisms.”
Self-citationIdakari, C. N., Anyigor-Ogah, C. S., Sunday-Nweke, N. A., et al. (2025) · Journal of Biosciences and Medicines · doi:10.4236/jbm.2025.137029 · Cited by 1 · see citing works
A Narrative Review of the Tale of the Dysbiotic Microbiome in the Preterm Neonate
Sowden, M., van Niekerk, E., Bulabula, A. N. H., & van Weissenbruch, M. M. (2023) · Dietetics · doi:10.3390/dietetics2040022 · Cited by 1 · see citing works
“Klebsiella pneumonia and Escherichia coli are the most frequently isolated species [87].”
BackgroundSelf-citationNjeuna, A., Founou, L. L., Founou, R. C., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.14.579597 · Cited by 1 · see citing works
Maternal Colonization, Perinatal Exposure, and Neonatal Acquisition of Resistant EnterobacteralesPreprint
Mithal, L. B., Sajwani, A., Aron, A., Kremer, A. N., Sumner, J. T., Manzano, V. C. C., Donnelly, G., Watson, A. D., Shuai, W., Miller, E. S., et al. (2024) · medRxiv · doi:10.1101/2024.06.28.24309630 · Cited by 1 · see citing works
Sgayer, I., Zidan, M., Francis, Y. N., Shqara, R. A., Glikman, D., Lowenstein, L., & Wolf, M. F. (2024) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2024.102755 · Cited by 1 · see citing works
Optimizing maternal care for better neonatal outcomes in AfricaPreprint
Dangor, Z., Bolaji, O., Tam, P. I., Lakhwani, J., Doaré, K. L., Manasyan, A., Mashingaidze-Mano, R., Nakabembe, E., Nggada, B. J., Okomo, U. A., et al. (2025) · doi:10.12688/verixiv.831.1
Self-citationHookham, L., Alger, J., Ramírez, F. A. D., Dissanayake, O., Frem, J. A., Herrera, O., Makanjuola, O., Martin-Jorge, I., Leach, J., Cross, J., et al. (2025) · Wellcome Open Research · doi:10.12688/wellcomeopenres.24905.1
Simba, S. M., Omwenga, E. O., Musyoki, S. K., et al. (2025) · International Journal of Community Medicine and Public Health · doi:10.18203/2394-6040.ijcmph20254411
Developing and implementing a family-led infection prevention bundle for hospitalized neonates
Tembo, C. V., Lechiile, K., Gopolang, B., et al. (2026) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-026-01705-y
Self-citationWan, T., Lautenbach, E., (22513336), N. M., et al. (2026) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiag342
Kashosi, T. M., Minutolo, A., Fiorilla, C., et al. (2026) · African Journal of Laboratory Medicine · doi:10.4102/ajlm.v15i1.2995
Optimizing maternal care for better neonatal outcomes in AfricaPreprint
Dangor, Z., Bolaji, O., Tam, P. I., Lakhwani, J., Doaré, K. L., Manasyan, A., Mashingaidze-Mano, R., Nakabembe, E., Nggada, B. J., Okomo, U. A., et al. (2026) · doi:10.12688/verixiv.831.3
Self-citationOptimizing maternal care for better neonatal outcomes in AfricaPreprint
Dramowski, A., Bolaji, O., Tam, P. I., Lakhwani, J., Doaré, K. L., Manasyan, A., Mashingaidze-Mano, R., Nakabembe, E., Nggada, B. J., Okomo, U. A., et al. (2026) · doi:10.12688/verixiv.831.4
Self-citation
- Authors
- Bulabula, A. N. H., Dramowski, A., & Mehtar, S.
- Affiliations
- Stellenbosch University (ZA)
- Corresponding author
- Bulabula, Andre N.H.
- Venue
- International Journal of Infectious Diseases
- Publisher
- Elsevier BV
- Published
- 2017-11
- Volume
- 64
- Pages
- 58-66
- ISSN
- 1201-9712 (ISSN-L)
- OpenAlex
- W2751088626
- Semantic Scholar
- 5afb9650df73b038019bfb8b54a85210149cab6b
- Cited by
- 59
- References
- 64
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 8 · 2023: 8 · 2022: 8 · 2021: 9 · 2020: 3 · 2019: 9 · 2018: 1
- FWCI
- 0.42
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Infectious Diseases (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- SUNScholar (Stellenbosch University) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Epidemiology › Urinary Tract Infections Management
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Antibiotic Use and Resistance
- Keywords
- extended-spectrum beta-lactamase, ESBL-producing Enterobacteriaceae, maternal colonization, maternal infection, pregnancy, postpartum women, prevalence, risk factors, CTX-M, community-acquired infections, neonatal colonization, antimicrobial resistance, Africa
- MeSH terms
- Africa, beta-Lactamases, Cefotaxime, Enterobacteriaceae, Enterobacteriaceae Infections, Female, Humans, Pregnancy, Pregnancy Complications, Infectious, Risk Factors, Prevalence, Postpartum Period
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-18.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-18.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review